Escherichia coli ranks among the organisms most frequently isolated from cases of bacteremia. The relative contribution of the host and bacteria to E. coli bacteremia severity remains unknown. We conducted a prospective multicenter cohort study to identify host and bacterial factors associated with E. coli bacteremia severity. The primary endpoint was in-hospital death, up to 28 days after the first positive blood culture. 
Recent reports indicate that the incidence of sepsis and the number of sepsis-related deaths are rising (29) , placing it now among the 10 leading causes of death in the United States (15) . Escherichia coli ranks among the organisms most frequently isolated from cases of sepsis, being the first most common cause of community-acquired and the fourth most common cause of nosocomial bacteremias (2, 11, 18, 26, 27, 49, 53) . With a case-fatality rate of 5 to 30%, E. coli bacteremia represents an increasingly important endemic problem, accounting for hundreds of thousands of lives lost and billions of health care dollars spent each year (40) . Worryingly, the spread, in recent years, of isolates producing extended-spectrum ␤-lactamases that are often resistant to most of the available antibiotic classes may further worsen the clinical and economic impact of E. coli bacteremia in the near future (43) .
E. coli is found in its primary habitat, the digestive tract, as a commensal (46) but is also involved in various intestinal and extraintestinal diseases. The genetic structure of the species is roughly clonal, with the delineation of at least four major phylogenetic groups, groups A, B1, B2, and D (12) . Pathogenic strains have been classified into various pathovars based on the conditions of their isolation and the presence of specific virulence genes (10) . In the case of extraintestinal pathogenic E. coli (ExPEC) strains (41) isolated during septicemia, numerous epidemiologic and experimental data have pointed to the roles of the B2-phylogroup-belonging strains and of numerous virulence factors involved in adhesion, toxin production, iron capture, and cell protection in the pathogenicity of the strain (3, 21, 35) .
Factors associated with E. coli bacteremia severity have not been clearly established. Relatively few studies have jointly examined the roles of host and bacterial factors in the severity and outcome of this infection (14, 17, 25, 30-32, 36, 50) . The discrepancies among the conclusions of those studies might reflect the retrospective (14, 31, 36, 50) and/or monocenter (14, 30, 32, 36, 50) nature of most of them, the small number (30 to 185) of patients included (14, 17, 30-32, 36, 50) , the small number of bacterial factors examined (14, 17, 25, 30-32, 36, 50) , and the diversity of the disease's pathophysiological mechanisms.
To overcome those limitations, we conducted a large prospective multicenter study aimed at characterizing the risk factors for E. coli bacteremia severity. Herein, we thoroughly analyzed the host determinants and bacterial genetic and antibiotic resistance characteristics of more than 1,000 consecu-tive E. coli bacteremia episodes occurring in adults over a 1-year period.
(This work was presented in part at the 49th International Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 12 to 15 September 2009 [26a] .)
MATERIALS AND METHODS
Study design and setting. This prospective COLIBAFI study was conducted in 15 French hospitals (1 general and 14 university hospitals). Adults with E. coli bacteremia between January and December 2005 were enrolled in the study. Only patients receiving vasopressors before the onset of E. coli bacteremia or patients already included in the study for a previous episode were not considered for inclusion.
E. coli bacteremia was defined as the isolation of E. coli from Ն1 set of aseptically inoculated blood culture bottles. The primary endpoint was in-hospital death, up to 28 days after the first positive blood culture.
Clinical and bacteriological data were collected in each center at the time of bacteremia by a dedicated physician and microbiologist in tandem. All E. coli isolates were centralized in 1 research laboratory (INSERM, UMR722), which performed molecular epidemiology studies. The study was approved by the institutional Ethics Committee (Comité de Protection des Personnes, Hôpital Saint-Louis, Paris, France; approval number 2004-06).
Clinical characteristics. Bacteremia episodes were defined as being nosocomial when the first positive blood culture was obtained Ն48 h following hospital admission. Otherwise, bacteremia was considered community acquired.
Immunocompromised patients were those presenting at least 1 of the following conditions: human immunodeficiency virus (HIV) infection with CD4 counts of Ͻ200 cells/mm 3 , underlying progressive solid cancer or malignant hemopathy, prior solid-organ or bone marrow transplantation, neutropenia of Ͻ500/mm 3 , congenital immunodeficiency, current immunosuppressive therapy (Ն10 mg/day of a prednisone equivalent, immunomodulating treatment, or antineoplastic chemotherapy within the last month).
The portal of entry was established according to compatible clinical and/or radiographic features and the isolation of E. coli from the presumed source of infection. When E. coli could not be isolated from the presumed portal of entry (i.e., previous antibiotic treatment leading to negative bacterial cultures or an undesirable invasive procedure needed to isolate E. coli from the portal of entry), the presumed portal of entry was assigned on the basis of a firm clinical suspicion, provided that all other possible sources of infection had been excluded. If the clinical data were ambiguous, the portal of entry was categorized as being "undetermined." A secondary septic focus was defined as a metastatic focus of infection due to bacteremia that was anatomically distant from the portal of entry, if any.
The bacteremia was polymicrobial when at least 1 other microorganism was recovered from a set of blood culture bottles positive for E. coli. The antibiotic regimen was considered to be adequate when the E. coli isolate was susceptible in vitro to at least 1 of the antibiotics given.
Follow-up ended at hospital discharge or 28 days after the first E. colipositive blood culture for patients still hospitalized 28 days after the bacteremia diagnosis.
Bacterial determinants. Strains were assigned to 1 of the 4 main E. coli phylogenetic groups, i.e., groups A, B1, B2, and D, using a triplex PCR developed previously by Clermont et al. (6) . The presence of 18 virulence factors representative of the main classes of identified E. coli extraintestinal virulence determinants (8, 20, 38, 39, 45) , including adhesins (papC; papG, including papG alleles; sfa/foc; iha; hra; and ibeA), toxins (hlyC, cnf1, and sat), iron capture systems (fyuA, irp2, iroN, iucC, and ireA), protectins (neuC, chromosomal ompT, and traT), as well as a gene encoding a uropathogenic-specific protein, usp (24) , were tested by PCR, as previously described (19) . For each isolate, a virulence score, defined as the number of virulence factors present over the 18 tested, was calculated. As it is well known that numerous virulence genes are clustered on genomic islands called pathogenicity-associated islands (PAIs) (13), we deduced the presence of 6 PAIs from the presence of the individual virulence genes (4, 16, 24) : PAI ICFT073 (papGII, hly, and iucC positive), PAI IIJ96 (presence of at least 3 of the 4 following genes: papGIII, hly, cnf1, and hra), PAI III536 (sfa/foc and iroN positive), PAI IV536 , a high-pathogenicity island (HPI) (irp2 and fyuA positive), GimA (ibeA positive), and PAI USP (usp positive). For each isolate, a PAI score, defined as the number of PAIs present over the 6 tested, was calculated.
Antimicrobial susceptibilities were determined for 18 antibiotics in each center with the disk diffusion method with Mueller-Hinton agar, as recommended by Comité de l'Antibiogramme de la Société Française de Microbiologie standards (http://www.sfm.asso.fr). A strain was considered to be resistant to expandedspectrum cephalosporins if it was resistant to cefotaxime and/or ceftazidime according to MICs determined by the Etest diffusion method (AB Biodisk, Solna, Sweden) (9) . A strain was considered to be multidrug resistant when it was resistant to at least amoxicillin, ofloxacin, and cotrimoxazole. For each strain, a resistance score was defined as the number of antibiotics to which it was resistant over the 5 following drugs: amoxicillin, cefotaxime, gentamicin, ofloxacin, and cotrimoxazole. The presence of integrons (classes I, II, and III), which are molecular markers of resistance, were detected by triplex real-time PCR (44) .
Statistical methods. Based on previous reports, the expected proportion of death was 15% (17, 25, 30, 53) . We therefore planned to include 1,000 patients. With 150 deaths and based on the general rule of 10 events by covariate, that number was needed to test about 15 clinical characteristics and 15 bacterial determinants.
The risk factors associated with death were analyzed. First, univariate regression analyses were performed for clinical and bacteriological factors. The studied clinical factors were age; sex; place of birth; weight; body mass index; hospitalization before bacteremia; antibiotic therapy during the 2 weeks preceding bacteremia; comorbidities, including a history of bacteremia, pregnancy, chronic alcoholism, tobacco addiction, congestive heart failure, chronic respiratory insufficiency, chronic renal insufficiency, cystic fibrosis, diabetes mellitus, sickle-cell anemia, immunocompromise, cirrhosis, or hemochromatosis; nosocomial infection; a portal of entry including urinary tract, digestive tract, pulmonary, cutaneous, venous catheter, female genital tract, or surgical site; and prescription of an adequate antibiotic regimen within the first day. The bacteriological determinants were as follows: a phylogenetic group in 4 classes; group B2; the presence of each of the 18 virulence factors; virulence score; the presence of each of the 6 PAIs; PAI score; polymicrobial sample; resistance to each of the drugs amoxicillin, cefotaxime, gentamicin, ofloxacin, and cotrimoxazole; resistance to expanded-spectrum cephalosporins; multidrug resistance; resistance score; and the presence of an integron of classes I, II, and/or III. The clinical and bacteriological risk factors achieving a P value of Ͻ0.10 were then entered into the multivariate logistic regression model. A backward selection method was used to obtain a model in which all clinical risk factors had a P value of Ͻ0.05. After that selection step, all interactions between 2 variables were tested, and all significant ones were retained in the model. The predictability of the final model was assessed by using the C statistic.
The risk factors for death were then also analyzed for the 2 subgroups of patients with the most frequent portals of entry, i.e., urinary or digestive tract, using an approach similar to that described above. Comparisons of some factors between urinary or digestive tract portals of entry were performed by using a Wilcoxon test for continuous variables and the Fisher exact test for discrete variables.
All these analyses were done with SAS 9.1 software (SAS Institute Inc., Cary, NC).
RESULTS
Among the 1,099 patients included in the study, 48 were excluded from the analysis because the E. coli isolates were not available (n ϭ 18) or the patient's clinical research forms were not filled out (n ϭ 30). Thus, 1,051 patients were retained for the analysis.
Clinical characteristics. The characteristics of the patients with E. coli bacteremia are shown in Table 1 . The patients were mostly Ͼ65 years old (638 patients [60.7%]) and predominantly female (57.5%). Overall, 19.2% of the bacteremias were nosocomial infections, and 9.1% occurred in patients living in nursing or retirement homes or a long-term care facility. At least one underlying immunocompromising comorbidity was reported for 37.9% of the patients. As expected, the most frequent portal of entry was the urinary tract (56.9% of the cases); a digestive tract portal of entry was identified for 13.1% of patients. Among 598 patients with a urinary tract source, 173 were male (including cases of presumed prostatitis [134 patients], pyelonephritis [32] , and orchiepididymitis [6] ) and 425 were female (all pyelonephritides). Among 138 patients with a digestive tract portal of entry, biliary tract infections predominated (angiocholitis [76 patients] and cholecystitis [33] but 778 LEFORT ET AL. J. CLIN. MICROBIOL.
also pancreatitis [23] , peritonitis [13] , diverticulitis [10] , appendicitis [4] , and liver abscess [4] ). Overall, 30 (2.9%) patients had at least 1 secondary septic focus of infection. Bacterial determinants. E. coli was isolated alone from the blood cultures of 988 patients, whereas for 63 (6.0%) patients bacteremias were polymicrobial. Five hundred forty-six strains (52.1%) and 219 strains (21.0%) belonged to the classical extraintestinal pathogenic E. coli phylogenetic groups (35), i.e., groups B2 and D, respectively; 236 (22.5%) belonged to phylogenetic group A, and only 48 (4.6%) belonged to group B1. The frequencies of the various virulence factors were highly variable, ranging from 8.3% for ibeA to 76.7% for irp2, a gene belonging to the high-pathogenicity island (42) (Fig. 1A) . The median virulence score for isolates was 9 (range, 0 to 18). Likely, the frequencies of PAIs ranged from 8.3% for GimA to 76.6% for the HPI, with PAI ICFT073 , PAI IIJ96 , PAI III536 , and PAI USP at 13, 18.7, 25.3, and 57.2%, respectively. The median PAI score for isolates was 2 (range, 0 to 6).
Rates of resistance to each antibiotic are shown in Fig. 1B ; 108 strains (10.3%) were multidrug resistant. Strains had a median resistance score of 1, ranging from no resistance to resistance to all the antibiotics tested; 39 (3.7%) were resistant to expanded-spectrum cephalosporins, among which 76.9% were community acquired. Three hundred fifteen strains (30.0%) possessed at least 1 integron, predominantly class I integrons (294 strains); a few class II (24 strains) and no class III integrons were detected.
Risk factors for death. Overall, 136 (12.9%) patients died. The median time to death was 6 days (range, 0 to 28). Clinical and bacterial factors associated with death were identified by univariate and multivariate analyses. The 13 clinical and 16 bacteriological risk factors significant in univariate analyses are reported in Table 2 . A significant interaction between immunocompromise and hospitalization before bacteremia was also entered into the model and yielded a new variable with 3 classes: not immunocompromised and not hospitalized before bacteremia, immunocompromised and not hospitalized before bacteremia, and hospitalized before bacteremia with or without immunocompromise; their corresponding odds ratios (ORs) (and 95% confidence intervals [CIs]) are reported in Table 2 .
After backward selection in the multivariate model, risk factors associated with death were older age, cirrhosis, hospitalization before bacteremia, immunocompromised patients not hospitalized before bacteremia, and a cutaneous portal of entry, whereas a urinary tract portal of entry and the presence of the bacteriological ireA virulence factor were negatively correlated with death ( Table 2 ). The C statistic of the final model was 0.77 (95% CI, 0.73 to 0.81) and was similar for the model with the same clinical factors but without the virulence factor ireA. These results show the good predictability of the model and the limited added value of the virulence factor in addition to clinical risk factors.
Relationship among portal of entry, host characteristics, and bacterial determinants. Because the urinary and the digestive tracts were the most frequently found portals of entry, and the pathophysiologies of E. coli bacteremias originating from the urinary or the digestive tract differ markedly, episodes were analyzed separately according to their urinary or digestive tract origin. Only isolates originating from patients with a single source (urinary or digestive tract) were considered for these subgroup analyses.
There were significantly more group B2 isolates among isolates of urinary tract origin (360/581 [62%]) than among those of digestive origin (43/129 [33.3%]) (P Ͻ 0.001). Virulence and PAI scores were significantly higher for isolates originating from the urinary tract than those from the digestive tract (medians, 10 [range, 0 to 17] and 2 [range, 0 to 6] versus 5 [range, 0 to 15] and 1 [range, 0 to 5], respectively; P Ͻ 0.001), whereas resistance scores did not differ (median, 1 [range, 0 to 5] for both portals of entry). All but 2 (traT and ibeA) of the 18 extraintestinal virulence factors and all but GimA of the PAIs analyzed were significantly more frequently found among isolates of urinary tract origin than among those of digestive tract origin (P Ͻ 0.05). The rate of death was higher among patients whose sepsis was of digestive tract origin (14.7%) than among those whose sepsis was of urinary tract origin (7.6%) (P ϭ 0.002). Table 3 reports the results of the multivariate analyses according to the urinary or digestive tract portal of entry. Clinical factors associated with death from sepsis of urinary tract origin were the same as those retained in the global model (Table 2) , plus tobacco addiction. No bacteriological factor was retrieved in this subgroup. For the subgroup with a digestive tract portal of entry, only cirrhosis and polymicrobial bacteremia were associated with death.
DISCUSSION
Through the prospective, multicenter, cohort COLIBAFI study, we thoroughly analyzed detailed host characteristics and numerous bacterial determinants that could potentially influence the E. coli bacteremia severity of Ͼ1,000 episodes. Our study was conducted during a recent 1-year period and thus provides original clinical and molecular epidemiological data on current aspects of E. coli bacteremia.
The results of our multivariate analyses showed that death was strongly associated with certain patient characteristics: older age, cirrhosis, hospitalization before bacteremia, and immunocompromised status for patients not hospitalized before the episode. Previous studies identified advanced age, health care or hospital acquisition, and comorbidities as host determinants associated with a poor outcome (25, 30, 36) . Surprisingly, a cutaneous portal of entry was also predictive of lifethreatening disease. E. coli isolates from skin and soft tissue infections usually belong to phylogenetic group B2 and have a high virulence potential (34) , but a link between that origin and E. coli bacteremia severity was never suggested previously. This result must be taken cautiously, as only 10 patients with a cutaneous portal of entry were included in the study. In contrast, a urinary tract portal of entry was associated with a less severe outcome, as previously reported (17, 25, 30, 36) . The only bacterial determinant that significantly influenced prognosis, although at a lower level than that of clinical determinants, was the presence of the ireA gene, which was found to negatively correlate with death ( Table 2 ). The ireA (iron-responsive element) gene encodes a peptide (IreA) suggested to be involved in iron acquisition and to be important in urovirulence (39) . IreA has been used with success as an immunizing agent in urinary tract infections (1) and bacteremia (52) in mice. Interestingly, this gene can be physically linked to the papC (pyelonephritis-associated pilus) gene and the papGII allele in the E. coli genome (22, 48) , both also involved in urinary tract infection and subsequent bacteremia (23, 33) . In our analysis, these two determinants have odds ratios similar to those of ireA in the univariate analysis (Table 2) . Thus, this part of the E. coli genome plays a crucial role in the occurrence of kidney infection and subsequent bacteremia but not in the latter's severity. These bacterial determinants are markers of the urinary tract origin of the bacteremia, which is associated with a better prognosis. Our findings indicate that host factors and portal of entry outweigh bacterial determinants in predicting the severity of E. coli bacteremia. The good predictability of the model with 6 clinical risk factors encourages the building of a prognostic score of death following bacteremia, which should be prospectively evaluated.
We then postulated that risk factors predictive of death might differ according to the portal of entry. For a urinary tract origin, the host characteristics predictive of death were the same as those retained in the overall analysis, plus tobacco addiction. No bacterial determinant was identified. For the digestive tract origin, cirrhosis was associated with life-threatening bacteremia. Cirrhotic patients have impaired mechanisms of hepatosplenic clearance (7) and are at an increased risk of bacteremia caused by poorly virulent strains colonizing the digestive tract. It was previously reported that the bacteremia prognosis for cirrhotic patients is highly guarded (5, 47) . We also found a link between the polymicrobial character of the bacteremia and death. It was previously shown that polymicrobial bacteremia was associated with higher mortality rates than unibacterial infection (37, 51) , but no previous studies evidenced this parameter as a risk factor for death in a subgroup of patients with a digestive tract source of bacteremia. Our study has several limitations. First, we did not analyze the impact of host genetic factors, which could have played a role in the severity of E. coli bacteremia. Second, we were unable to determine the portal of entry for 26.8% of the episodes. Third, although we looked at 18 virulence factors, either individually or grouped into PAIs, we are far from having tested all the genes of the variable E. coli gene pool (48) and their different combinations. It was shown from the complete sequence analysis of some natural isolates that multiple constellations of genes can lead to a virulent phenotype (48) . High-throughput sequencing technologies (28) will allow the performance of comparative genomic analyses on numerous strains and the performance of phenotype-genotype association studies in the near future.
Despite these limitations, our analysis based on 15 centers and Ͼ1,000 patients, and its prospective design, enhanced our ability to draw conclusions. Death following E. coli bacteremia is associated mainly with host characteristics and the portal of entry. Thus, the early identification of clinical risk factors for severe progression is essential to optimize the timely management of patients with E. coli bacteremia. 
